Daiwa Securities Group
OMIC

Daiwa Securities Group’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Daiwa Securities Group’s Portfolio OMIC Stock Details OMIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-7
Closed -$1K – 1408
2022
Q3 		$1K Hold
7
– – ﹤0.01% 1323
2022
Q2 		$1K Hold
7
– – ﹤0.01% 1335
2022
Q1 		$1K Hold
7
– – ﹤0.01% 1355
2021
Q4 		$2K Buy
+7
New +$2.71K ﹤0.01% 1312

Other funds holding OMIC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Daiwa Securities Group's OMIC Position: Q4 2022 in Review

Daiwa Securities Group sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q4 2022, closing a stake of 7 shares — an estimated $1K sold.

Daiwa Securities Group first reported a position in OMIC in Q4 2021 and held it in 4 quarters. The position peaked at $2K in Q4 2021. 80 funds tracked by Wall St. Rank hold OMIC as of Q4 2022.

  • Daiwa Securities Group reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Daiwa Securities Group sold 7 Singular Genomics Systems, Inc. Common Stock shares in Q4 2022, an estimated $1K.
  • Daiwa Securities Group first reported a position in Singular Genomics Systems, Inc. Common Stock in Q4 2021 and held it in 4 quarters.
  • Daiwa Securities Group's Singular Genomics Systems, Inc. Common Stock position peaked at $2K in Q4 2021.
  • 80 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q4 2022.

Based on Daiwa Securities Group's 13F filing for Q4 2022, filed 6 Feb 2023.